A doctor talking with an older patient at home

Clinical research directory · Four states

Discover research studies in obesity & diabetes.

Explore selected publicly registered clinical studies with reported research locations in Arizona, California, Hawaii and Utah. Compare study focus, location and basic participation criteria—then review the official study record.

  • 8 recruiting studiesPlus 2 no longer recruiting · not a complete list
  • 4 statesArizona · California · Hawaii · Utah
  • Checked against the registryOctober 21, 2026

Explore clinical studies

Study status and locations reflect public registry information as of October 21, 2026, not guaranteed appointment or enrollment availability.

10 studies match your selection

Registry: recruitingPhase 3NCT07282600

ENLIGHTEN-2: Eloralintide for obesity with type 2 diabetes

Adults with obesity or overweight and type 2 diabetes; the study evaluates weight reduction with investigational eloralintide.

Research area
Obesity and type 2 diabetes

Basic study criteria: Age 18+; type 2 diabetes; BMI ≥27; stable diabetes treatment.

Selected registry-listed research locations

  • Tucson Clinical Research Institute — Tucson, AZ
  • San Fernando Valley Health Institute — Canoga Park, CA
  • AMCR Institute — Escondido, CA
  • NorCal Medical Research, Inc — Greenbrae, CA

Plus 9 more locations in this directory. Site recruitment may change.

View studyStudy record updated Oct 8, 2026
Registry: recruitingPhase 3NCT07321886

ENLIGHTEN-1: Eloralintide for obesity without type 2 diabetes

Adults with obesity or overweight without type 2 diabetes; study compares investigational eloralintide with placebo.

Research area
Obesity without type 2 diabetes

Basic study criteria: Age 18+; BMI ≥30, or ≥27 plus a weight-related condition; people with type 2 diabetes excluded.

Selected registry-listed research locations

  • Headlands Research - Scottsdale — Scottsdale, AZ
  • Neighborhood Healthcare Institute of Health — Escondido, CA
  • Ark Clinical Research - Fountain Valley — Fountain Valley, CA
  • Desert Oasis Healthcare Medical Group — Palm Springs, CA

Plus 5 more locations in this directory. Site recruitment may change.

View studyStudy record updated Sep 22, 2026
Registry: recruitingPhase 3NCT07351045

Enicepatide for obesity without type 2 diabetes

Study evaluates investigational enicepatide for weight management in adults without type 2 diabetes.

Research area
Obesity without type 2 diabetes

Basic study criteria: Age 18+; BMI ≥30, or ≥27 with a weight-related condition; diabetes excluded.

Selected registry-listed research locations

  • Arizona Clinical Trials — Tucson, AZ
  • University of California Irvine — Irvine, CA
  • Artemis Institute for Clinical Research, LLC — San Diego, CA
  • Diablo Clinical Research, Inc. — Walnut Creek, CA

Plus 2 more locations in this directory. Site recruitment may change.

View studyStudy record updated Oct 13, 2026
Registry: recruitingPhase 3NCT07351058

Enicepatide for obesity with type 2 diabetes

Study evaluates investigational enicepatide for weight management among adults living with type 2 diabetes.

Research area
Obesity and type 2 diabetes

Basic study criteria: Age 18+; BMI ≥27; type 2 diabetes with specified HbA1c and stable treatment.

Selected registry-listed research locations

  • Arizona Clinical Trials — Tucson, AZ
  • University of California Irvine — Irvine, CA
  • Orange County Research Center — Lake Forest, CA
  • Ark Clinical Research — Long Beach, CA

Plus 4 more locations in this directory. Site recruitment may change.

View studyStudy record updated Oct 13, 2026
Registry: recruitingPhase 2NCT07589608

Macupatide and eloralintide for weight management

Study investigates two investigational medicines, separately or together, in adults with obesity or overweight without type 2 diabetes.

Research area
Obesity without type 2 diabetes

Basic study criteria: Ages 18–75; no type 1 or type 2 diabetes; additional master protocol criteria.

Selected registry-listed research locations

  • Arizona Clinical Trials - Mesa — Chandler, AZ
  • Headlands Research - Scottsdale — Scottsdale, AZ
  • Arizona Liver Health - Tucson — Tucson, AZ
  • NorCal Medical Research, Inc — Greenbrae, CA

Plus 3 more locations in this directory. Site recruitment may change.

View studyStudy record updated Oct 8, 2026
Registry: recruitingPhase 3NCT07575399

MARITIME-SWITCH: Switching GLP-1 medicines

Study evaluates switching from a weekly GLP-1 medicine to investigational maridebart cafraglutide in adults with obesity or overweight.

Research area
Obesity without type 2 diabetes

Basic study criteria: Age 18+; already using a stable weekly GLP-1 medicine with prior weight loss; diabetes excluded.

Selected registry-listed research locations

  • Arizona Clinical Trials — Chandler, AZ
  • Epic Medical Research - Sun City — Sun City, AZ
  • Clinical Research Institute of Arizona LLC — Sun City West, AZ
  • Desert Oasis Healthcare Medical Group — Palm Springs, CA

Plus 5 more locations in this directory. Site recruitment may change.

View studyStudy record updated Oct 20, 2026
Registry: recruitingPhase 3NCT07770841

Oral semaglutide dose study for weight management

Study compares investigational lower oral semaglutide doses with placebo for weight management.

Research area
Obesity without type 2 diabetes

Basic study criteria: Age 18+; BMI ≥30, or ≥27 with a weight-related condition; additional lab and medication restrictions.

Selected registry-listed research locations

  • Headlands Research California, LLC — Escondido, CA
  • National Research Institute - Huntington Park — Huntington Park, CA
  • Los Angeles Institute for Metabolic Research — Los Angeles, CA
  • East West Med Res Inst — Honolulu, HI

Site recruitment may change.

View studyStudy record updated Sep 9, 2026
Registry: recruitingPhase 3NCT07817251

CagriSema switching study in type 2 diabetes

Study examines safety and tolerability when adults with type 2 diabetes switch from semaglutide to investigational CagriSema.

Research area
Type 2 diabetes

Basic study criteria: Age 18+; type 2 diabetes; currently on relevant semaglutide treatment; study team determines fit.

Selected registry-listed research locations

  • Gilbert Center For Family Medicine — Gilbert, AZ
  • Ark Clinical Research — Fountain Valley, CA
  • Thrive Clinical Research Group — Glendora, CA
  • Scripps Whittier Diabetes Inst — La Jolla, CA

Plus 9 more locations in this directory. Site recruitment may change.

View studyStudy record updated Sep 30, 2026
Registry: active, not recruitingPhase 3NCT07284875

KaiNETIC-1: Ribupatide for obesity without diabetes

Adults with obesity, or overweight with a weight-related condition, without diabetes; the study compares investigational ribupatide with placebo.

Research area
Obesity without type 2 diabetes

Basic study criteria: Age 18+; BMI ≥30, or ≥27 with a weight-related condition; diabetes excluded.

Selected registry-listed research locations

  • Kailera clinical site (name not disclosed) — Sun City, AZ
  • Kailera clinical site (name not disclosed) — Escondido, CA
  • Kailera clinical site (name not disclosed) — Toluca Lake, CA
  • Kailera clinical site (name not disclosed) — Salt Lake City, UT

Not enrolling new participants.

View studyStudy record updated Oct 6, 2026
Registry: active, not recruitingPhase 3NCT07284979

KaiNETIC-3: Ribupatide compared with semaglutide

Adults with obesity without diabetes; the study compares investigational ribupatide with semaglutide and with placebo.

Research area
Obesity without type 2 diabetes

Basic study criteria: Age 18+; BMI ≥35; diabetes excluded.

Selected registry-listed research locations

  • Kailera clinical site (name not disclosed) — Glendale, AZ
  • Kailera clinical site (name not disclosed) — Phoenix, AZ
  • Kailera clinical site (name not disclosed) — Northridge, CA
  • Kailera clinical site (name not disclosed) — Oceanside, CA

Not enrolling new participants.

View studyStudy record updated Oct 6, 2026

From discovery to clinical review

Our proposed InvestigatorX workflow supports responsible identification and communication. Study investigators make all eligibility and enrollment decisions.

  1. 01MatchExplore potential study opportunities based on public criteria and geography.
  2. 02ValidateDiscuss whether a study makes sense with your treating clinician.
  3. 03ScreenThe authorized study team reviews eligibility and follows its approved consent process.
  4. 04EnrollParticipants may enroll only if eligible and after providing appropriate informed consent.